Billions flow to Och-Ziff Capital Management Group, Despite sub-par Performance & bad press

September 8th, 2014
| More
Despite its underperformance thus far in 2014, Och-Ziff Capital Management Group has managed to increase its assets under management during the first nine months of the year. As reported by CNBC, the global hedge fund firm has seen its assets rise to $46 billion, adding nearly $6 billion year-to-date. Institutional investors continue to look to Och-Ziff Capital Management Group for stable, long-term, risk-adjusted returns.

Och-Ziff’s flagship OZ Master Fund, which has generated annualized returns of 10 percent over the last 15 years, is up just over 2.5 percent in the first three quarters, while its Asian and Europe-focused funds are also off for the year thus far.

Notably, Och-Ziff Capital has seen inflows, despite also being subject to bad press surrounding alleged violations of the Foreign Corrupt Practices Act.
For Detailed Investor Profiles on these Investors, click below:
Och-Ziff Capital Management
Related People: Daniel Och; David Windreich; Harold Kelly; Michael Cohen*; Zoltan Varga
Related Entities: Och-Ziff Capital Structure Arbitrage; OZ Credit Opportunities; OZ Master Fund; Ziff Brothers
Related Article Tags: Multi-Strategy, Long Short, Equity, Debt and Global Macro Hedge Fund News

More Recent Headlines

Assets jump by nearly 18% for leading Emerging Hedge Fund Managers; Soroban Capital, Corvex Management & Roystone Capital power gains

Top Mid-Sized Hedge Fund List Revealed; Newbrook Capital Advisors and Decade Capital Management claim top spots

Blackstone Group ramps up hiring for big launch of the Blackstone Senfina Advisors hedge fund

California Hedge Funds continue to thrive, Assets surge by 13.5 percent

SAC’s Point72 Asset Management loses Thomas Conheeney; Gabriel Plotkin to launch Melvin Capital

“Best Ideas” hedge fund launched by Soroban Capital Partners

What a Difference a Year Makes, Many Hedge Fund Stars are falling in 2014

Apple regains credence with top Hedge Funds: Discovery Capital, Coatue Management, Greenlight & Icahn

AIFMD Depositary: Developing an Operating Model

Healthcare & Biotech Hedge Funds see asset surge 12%; Glenview Capital, OrbiMed & Visium lead gainers